It's hard to believe that six months have passed since we released the 11th edition of our Biotech Review of the Year publication. Our...

This article is part of our Biotech Review of the Year - Issue 11 publication Introduction The European Commission (EC) published its...

This article is part of our Biotech Review of the Year - Issue 11 publication The biopharmaceutical landscape is undergoing a steady but...

This article is part of our Biotech Review of the Year - Issue 11 publication Ellen Lambrix and Marek Petecki in conversation with Brad...

This article is part of our Biotech Review of the Year - Issue 11 publication The UK Government has announced significant investment...

This article is part of our Biotech Review of the Year - Issue 11 publication On 4 May 2023, the Court of Appeal, with the leading...

This article is part of our Biotech Review of the Year - Issue 11 publication Following years of gestation the UPC finally opened its...

This article is part of our Biotech Review of the Year - Issue 11 publication On 27 April 2023 the Commission put forward new proposals...

This article is part of our Biotech Review of the Year - Issue 11 publication In 2023, the European Commission (EC) proposed its most...

This article is part of our Biotech Review of the Year - Issue 11 publication The creation and use of synthetic data holds great...

This article is part of our Biotech Review of the Year - Issue 11 publication Readers will be well aware of the explosion in the use of...

This article is part of our Biotech Review of the Year - Issue 11 publication The ethos of Bryan Johnson, a billionaire whose campaign to...